I'm downgrading InMode from a 'Strong Buy' to a 'Buy' due to consistent guidance cuts and short-term demand issues. Despite recent performance issues and high interest rates, INMD still holds a strong ...

YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement ...

InMode (INMD) posted a net profit margin of 44.5%, outpacing last year's mark of 35.8%, as annual earnings climbed 19.8%, notably ahead of the company’s 11.8% five-year average. Revenue is forecast to ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we'll explain below. However, now that it's down 76% from highs, ...

InMode INMD is preparing to release its quarterly earnings on Monday, 2025-04-28. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect InMode to ...

A foreign investment fund could scoop up medical aesthetics outlet InModeINMD for $1.1 billion, an analyst said Monday as InMode stock surged to a three-month high. Calcalist, an Israeli news outlet, ...